Adding Talazoparib to Enzalutamide Prolongs Imaging-Based PFS in Metastatic Androgen Pathway Modulation-Sensitive Prostate Cancer with Alterations in HRR Genes By Ogkologos - June 15, 2026 55 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TALAPRO-3 study Source RELATED ARTICLESMORE FROM AUTHOR Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors MOST POPULAR Study Provides Closer Look at Postmenopausal Bleeding and Endometrial Cancer August 29, 2018 Data Shows Women Are Not Getting Access To An Important Part... July 30, 2021 Reducing the Cancer Burden: Future Directions for NCI’s Cancer Control Research December 19, 2022 Two Early Studies Show Rapid Antitumour CAR-Mediated Responses, but Often of... March 20, 2024 Load more HOT NEWS Sacituzumab Govitecan Plus Pembrolizumab Demonstrate Encouraging Activity in Patients with mUC... Coping With the Difficult Times of Cancer Survivorship Through My “Bucket... Two Early Studies Show Rapid Antitumour CAR-Mediated Responses, but Often of... COVID-19 vaccine and cancer – latest updates
